Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-07), Ingevity's 12-1 Month Momentum % is N/A%.
The industry rank for Ingevity's 12-1 Month Momentum % or its related term are showing as below:
MEX:NGVT's 12-1 Month Momentum % is not ranked *
in the Chemicals industry.
Industry Median: 2.27 * Ranked among companies with meaningful 12-1 Month Momentum % only.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Ingevity 12-1 Month Momentum % Related Terms
MEX:NGVT vs CC, KWR, MTX: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Ingevity's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Ingevity's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (MEX:NGVT) has a 12-1 Month Momentum % of N/A% as of Aug. 07, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Ingevity and its competitors. According to the industry distribution chart, Ingevity ranks #299 out of 1607 companies in the Chemicals industry, placing it in the top 18.6%.
Is Ingevity's 12-1 Month Momentum % too high?
Ingevity's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, Ingevity ranks #299 out of 1607 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Ingevity has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's 12-1 Month Momentum % compare to CC and KWR?
According to the Chemicals industry distribution chart, Ingevity ranks #299 out of 1607 companies for 12-1 Month Momentum %. This places Ingevity in the top 19% of its industry — outperforming the majority of peers. The industry median 12-1 Month Momentum % is 2.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
The median 12-1 Month Momentum % among Chemicals companies is 2.27, based on 1,607 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Ingevity and its competitors. For the Chemicals industry, the median 12-1 Month Momentum % is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ingevity's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (MEX:NGVT) has a current 12-1 Month Momentum % of N/A%. The stock's GF Value™ is MXN853.86, compared to a current price of MXN1,430.00 — trading 67.5% above its estimated fair value. The current 12-1 Month Momentum % is N/A%. Ingevity's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Ingevity (MEX:NGVT), the current 12-1 Month Momentum % is N/A% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (MEX:NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of MXN1,430.00 is trading 67.5% above its estimated GF Value™ of MXN853.86.
Key valuation signals for MEX:NGVT:
12-1 Month Momentum %: N/A%
GF Value™: MXN853.86 vs. price of MXN1,430.00 (67.5% above fair value)
No single metric tells the full story. See the MEX:NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score
Get the complete analysis for MEX:NGVT
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NGVT has been successfully added to your 
